Galmed Pharmaceuticals Ltd (GLMD) — Cash Flow-to-Debt Ratio

Latest as of June 2026: -0.38x

Galmed Pharmaceuticals Ltd (GLMD) has a Cash Flow-to-Debt Ratio of -0.38x as of June 2026, meaning its operating cash flow of $-2.13 Million could theoretically repay 0% of its total liabilities ($5.54 Million) in one year. See financial agility of Galmed Pharmaceuticals Ltd to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

-0.38x
Operating CF / Total Liabilities

Operating Cash Flow

$-2.13 Million
USD

Total Liabilities

$5.54 Million
USD

Data as of

Jun 2026
Most recent filing

Galmed Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2012–2025)

Historical debt coverage capacity for Galmed Pharmaceuticals Ltd across 14 annual periods. For the full cash flow conversion analysis, see Galmed Pharmaceuticals Ltd operating cash flow efficiency.

Annual Cash Flow-to-Debt Ratio for Galmed Pharmaceuticals Ltd (2012–2025)

Year-by-year debt coverage analysis for Galmed Pharmaceuticals Ltd.

Year CF-to-Debt Ratio Operating CF (USD) Total Liabilities YoY Change
2025 -2.22x $-6.32 Million $2.85 Million ▲ +18.0%
2024 -2.71x $-5.88 Million $2.17 Million ▼ -21.3%
2023 -2.23x $-6.14 Million $2.75 Million ▲ +62.1%
2022 -5.90x $-18.50 Million $3.14 Million ▼ -9.5%
2021 -5.39x $-32.89 Million $6.11 Million ▼ -68.6%
2020 -3.19x $-26.29 Million $8.23 Million ▼ -55.8%
2019 -2.05x $-14.94 Million $7.29 Million ▲ +38.5%
2018 -3.33x $-9.02 Million $2.71 Million ▼ -6.3%
2017 -3.14x $-12.07 Million $3.85 Million ▼ -39.0%
2016 -2.26x $-12.13 Million $5.38 Million ▲ +27.6%
2015 -3.12x $-8.47 Million $2.72 Million ▲ +48.8%
2014 -6.09x $-9.24 Million $1.52 Million ▼ -410.6%
2013 -1.19x $-2.52 Million $2.12 Million ▼ -6.1%
2012 -1.12x $-3.08 Million $2.74 Million
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.